ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Disclosure under Insider Trading Regulations28-05-2022
28-05-2022
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Disclosure under Insider Trading Regulations27-05-2022
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Intimation under SEBI PIT regulation 7(2)26-05-2022
Buy Zydus Lifesciences; target of Rs 445: KR Choksey
KR Choksey is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 445 in its research report dated May 25, 2022.26-05-2022
Zydus sees no significant business from ZyCoV-D with negligible demand
Company will now focus on exports and private market sale, besides working on multi-variant vaccine23-05-2022
Buy Zydus Lifesciences: target of Rs 440: Sharekhan
Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 440 in its research report dated May 20, 2022.21-05-2022
Zydus Lifesciences gets board nod for 750-cr share buyback
Company will buy back 1.13% of total equity shares at a price of 650/share20-05-2022
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Investor Call20-05-2022
Buy Zydus Wellness: target of Rs 2250: Sharekhan
Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 2250 in its research report dated May 17, 2022.18-05-2022
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting dated May 18, 2022 with regard to audited financial results of the Company for the quarter / year ended on March 31, 202218-05-2022